Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Convulsions and hyperglycaemia associated with nalidixic acid

A G Fraser, A D Harrower

    British Medical Journal
    |December 10, 1977
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Inclusion and reporting by age, sex, and ethnicity in clinical studies of high-risk medical devices approved in the European Union.

    European heart journal. Quality of care & clinical outcomes·2025
    Same author

    Survey of Notified Bodies reveals very limited use of conditional certification for high-risk medical devices.

    Frontiers in medical technology·2025
    Same author

    Improved clinical investigation and evaluation of high-risk medical devices: the rationale and objectives of CORE-MD (Coordinating Research and Evidence for Medical Devices).

    European heart journal. Quality of care & clinical outcomes·2021
    Same author

    Letter response: Prevalence of subclinical cardiac abnormalities in patients with metal-on-metal hip replacements.

    International journal of cardiology·2019
    Same author

    Prevalence of subclinical cardiac abnormalities in patients with metal-on-metal hip replacements.

    International journal of cardiology·2018
    Same author

    Editorial: replacing standard proton pump inhibitors with vonoprazan may breathe new life into triple therapy for Helicobacter pylori.

    Alimentary pharmacology & therapeutics·2017